Hiroaki Ohata

Designation: Director / Medical Affairs Lead Autoimmune Diseases Products, Bio-Medicines Japan Drug Development and Medical Affairs & Medical Affairs Committee Working Group 3

Department: Eli Lilly Japan K.K. / PhRMA